CatalYm
Presence
Acquisition, funding and merger involving CatalYm.
- CatalYm has just announced a $50 Million fundraising (posted on November 29 2022).
Executives
View the org chart displaying its 14 main executives
Most searched biographies at CatalYm
- Phil L'Huillier, Managing Director and Chief Executive Officer
- Hans van Eenennaam, Director
- Marc Lohrmann, Director
Popular executive movements at CatalYm
- Roy Baynes has joined the company as Director (posted on January 9 2024).
Create your alert
to follow the executive moves at CatalYm.
Biotechnology
CatalYm has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by CatalYm
Social media about CatalYm
- CatalYm on Wikipedia, Google News & Yahoo Finance
- CatalYm on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Phil L'Huillier 
